Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
OXB

Oxford Biomedica plc

OXBLSEUnited KingdomHealthcareBiotechnologyFTSE 250

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with…more

P/B8.52xROIC-18.0%
£779.48M
Market Cap
EV: £828.87M
MOM9
QUAL5
VAL1
RSK9
OXB
£779.48M
Market Cap · EV £828.87M

Oxford Biomedica plc

MOM9
QUAL5
VAL1
RSK9

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with…more

Latest RNS from Oxford Biomedica plc

Analyst consensus: Buy

As of 22 Jul 2026, 8 analysts rate Oxford Biomedica plc a Buy, with 88% buy ratings and a mean price target of 842p (range 550p–1,140p), +40% vs the current price.

Strong buy: 1Buy: 6Hold: 1Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies